These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 22205526)
41. Botulinum Toxin Type-A (BoNT-A) Injections of the Corrugator Muscles for Aesthetics and Depression? Brennan C Plast Surg Nurs; 2016; 36(4):167-169. PubMed ID: 27922559 [TBL] [Abstract][Full Text] [Related]
42. Treatment of wrinkles with Botox. Klein AW Curr Probl Dermatol; 2002; 30():188-217. PubMed ID: 12471713 [No Abstract] [Full Text] [Related]
43. Practical aspects of cosmetic botulinum toxin. Mannor GE Int Ophthalmol Clin; 2005; 45(3):99-106. PubMed ID: 15970769 [No Abstract] [Full Text] [Related]
44. Botulinum Toxin A in bruxers. One year experience. Redaelli A Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762 [TBL] [Abstract][Full Text] [Related]
46. Botulinum toxin below the eyes. Carruthers J; Carruthers A Int Ophthalmol Clin; 2005; 45(3):133-41. PubMed ID: 15970772 [No Abstract] [Full Text] [Related]
47. Gummy smile and botulinum toxin: a new approach based on the gingival exposure area. Mazzuco R; Hexsel D J Am Acad Dermatol; 2010 Dec; 63(6):1042-51. PubMed ID: 21093661 [TBL] [Abstract][Full Text] [Related]
48. [Can the botulinum toxin prevent aging?]. Le Louarn C Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S92-103. PubMed ID: 19576493 [TBL] [Abstract][Full Text] [Related]
49. [Botulinum toxin injections for facial rejuvenation]. Société Française de Chirurgie Plastique Reconstructrice et Esthétique Ann Chir Plast Esthet; 2004 Oct; 49(5):553-6. PubMed ID: 15600009 [No Abstract] [Full Text] [Related]
50. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience. Farahvash MR; Arad S J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691 [TBL] [Abstract][Full Text] [Related]
51. Primary and adjunctive uses of botulinum toxin type A in the periorbital region. Balikian RV; Zimbler MS Facial Plast Surg Clin North Am; 2005 Nov; 13(4):583-90, vii. PubMed ID: 16253845 [TBL] [Abstract][Full Text] [Related]
53. [Consensus recommendations on the use of botulinum toxin type A in aesthetic medicine]. Sommer B; Bergfeld D; Sattler G J Dtsch Dermatol Ges; 2007 Feb; 5 Suppl 1():S1-S29. PubMed ID: 17229195 [No Abstract] [Full Text] [Related]
54. Botulinum toxin for chronic migraine. Med Lett Drugs Ther; 2011 Jan; 53(1356):7-8. PubMed ID: 21252842 [No Abstract] [Full Text] [Related]
57. An overview of the cosmetic treatment of facial muscles with a new botulinum toxin. Wiest LG Acta Dermatovenerol Croat; 2009; 17(1):48-53. PubMed ID: 19386215 [TBL] [Abstract][Full Text] [Related]
58. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use]. Sheen-Ophir S; Almog Y Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501 [TBL] [Abstract][Full Text] [Related]
60. Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Dubinsky RM Clin Rehabil; 2010 Aug; 24(8):766. PubMed ID: 20702516 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]